Literature DB >> 6285369

Phosphorus-containing inhibitors of angiotensin-converting enzyme.

E D Thorsett, E E Harris, E R Peterson, W J Greenlee, A A Patchett, E H Ulm, T C Vassil.   

Abstract

Several phosphonamides, phosphoramides, and phosphates having the general structure R-Y-P(O)(OH)-X-CH(CH3)-CO-Pro have been synthesized and tested for inhibition of angiotensin-converting enzyme (dipeptidyl carboxypeptidase; peptidyl-dipeptide hydrolase, EC 3.4.15.1). Inhibition was found to depend on the nature of R, Y, and X such that the maximal effect was observed when X = NH, Y = CH2, and R = phi CH2 (50% inhibition at 7 nM). Substitution of CH2 or O at X and O at Y produced significantly less potent inhibitors. Groups shorter or longer than R = phi CH2 led to less active inhibitors, presumably due to nonoptimal interaction of the side chain with the S1 subsite.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6285369      PMCID: PMC346153          DOI: 10.1073/pnas.79.7.2176

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Studies on inhibitory effect of phosphoramidon and its analogs on thermolysin.

Authors:  T Komiyama; H Suda; T Aoyagi; T Takeuchi; H Umezawa
Journal:  Arch Biochem Biophys       Date:  1975-12       Impact factor: 4.013

2.  Pulmonary angiotensin-converting enzyme. Structural and catalytic properties.

Authors:  M Das; R L Soffer
Journal:  J Biol Chem       Date:  1975-09-10       Impact factor: 5.157

3.  Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids.

Authors:  D W Cushman; H S Cheung; E F Sabo; M A Ondetti
Journal:  Biochemistry       Date:  1977-12-13       Impact factor: 3.162

4.  A crystallographic study of the complex of phosphoramidon with thermolysin. A model for the presumed catalytic transition state and for the binding of extended substances.

Authors:  L H Weaver; W R Kester; B W Matthews
Journal:  J Mol Biol       Date:  1977-07       Impact factor: 5.469

5.  Inhibition of angiotensin-coverting enzyme by analogs of peptides from Bothrops jararaca venom.

Authors:  D W Cushman; J Pluscec; N J Williams; E R Weaver; E F Sabo; O Kocy; H S Cheung; M A Ondetti
Journal:  Experientia       Date:  1973-08-15

6.  An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients.

Authors:  H Gavras; H R Brunner; J H Laragh; J E Sealey; I Gavras; R A Vukovich
Journal:  N Engl J Med       Date:  1974-10-17       Impact factor: 91.245

7.  Letter: A thermolysin inhibitor produced by Actinomycetes: phospholamidon.

Authors:  H Suda; T Aoyagi; T Takeuchi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1973-10       Impact factor: 2.649

8.  [Synthesis of desoxyoligonucleotides with trichlorethyl-phosphate-protecting groups].

Authors:  A Franke; F Eckstein; K H Scheit; F Cramer
Journal:  Chem Ber       Date:  1968

9.  A general transesterification method for the synthesis of mixed trialkyl phosphates.

Authors:  K K Ogilvie; S L Beaucage; N Theriault; D W Entwistle
Journal:  J Am Chem Soc       Date:  1977-02-16       Impact factor: 15.419

10.  Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.

Authors:  D B Case; J M Wallace; H J Keim; M A Weber; J E Sealey; J H Laragh
Journal:  N Engl J Med       Date:  1977-03-24       Impact factor: 91.245

View more
  5 in total

1.  Inhibitors of angiotensin-converting enzyme containing a tetrahedral arsenic atom.

Authors:  R E Galardy; Z P Kortylewicz
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

2.  Polyclonal antibody-catalysed amide hydrolysis.

Authors:  G Gallacher; M Searcey; C S Jackson; K Brocklehurst
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

3.  Potent inhibition of endopeptidase 24.16 and endopeptidase 24.15 by the phosphonamide peptide N-(phenylethylphosphonyl)-Gly-L-Pro-L-aminohexanoic acid.

Authors:  H Barelli; V Dive; A Yiotakis; J P Vincent; F Checler
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

4.  Chemical reactivity at an antibody binding site elicited by mechanistic design of a synthetic antigen.

Authors:  A Tramontano; K D Janda; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Design, Synthesis and Evaluation of Novel 2-Hydroxypyrrolobenzodiazepine-5,11-dione Analogues as Potent Angiotensin Converting Enzyme (ACE) Inhibitors.

Authors:  Ying Sun; Yujun Bai; Xirui He; Yajun Bai; Pei Liu; Zefeng Zhao; Xufei Chen; Xiaohui Zheng
Journal:  Molecules       Date:  2017-11-03       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.